Paradigm Biocapital Advisors »

Y Mabs Therapeutics shares owned by Paradigm Biocapital Advisors

Quarter-by-quarter ownership of Y Mabs Therapeutics (YMAB) shares owned by Paradigm Biocapital Advisors from 13F filings

Historical chart of Paradigm Biocapital Advisors investment in Y Mabs Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Y Mabs Therapeutics held by Paradigm Biocapital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Y Mabs Therapeutics by Paradigm Biocapital Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $36M 2.2M 16.26